The purpose of this study is to determine the effectiveness of RXI-109 in reducing the recurrence of hypertrophic scar formation following elective revision of a pre-existing hypertrophic abdominal scar.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
25
Unnamed facility
Lake Worth, Florida, United States
Unnamed facility
Chicago, Illinois, United States
Unnamed facility
St Louis, Missouri, United States
Unnamed facility
Huntersville, North Carolina, United States
Unnamed facility
Reduction in recurrence of hypertrophic scarring after scar revision surgery
To evaluate the effectiveness of RXI-109 in reducing the recurrence of hypertrophic scar formation following elective revision of a hypertrophic abdominal scar
Time frame: 9 months
Safety of RXI-109
To assess severity and frequency of reported adverse events and clinically-relevant changes in laboratory testing after elective revision of a hypertrophic abdominal scar
Time frame: 9 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
San Pedro Sula, Honduras